期刊文献+

2型糖尿病患者血小板参数与尿微量清蛋白及β_2-MG测定结果分析 被引量:1

Study on detection of platelet parameters,microalbuminuria and β_2-MG in the datiests with type 2 diabetes
暂未订购
导出
摘要 目的探讨2型糖尿病患者血小板参数及尿微量清蛋白(ALB)、β2-微球蛋白(β2-MG)的变化特点和临床价值。方法对54例2型糖尿病患者及39例健康成人进行血小板计数(PLT)、血小板平均体积(MPV)、血小板分布宽度(PDW)及ALB、β2-MG的联合对比检测。结果2型糖尿病患者与健康对照组比较,PLT差异无统计学意义(P>0.05);MPV、PDW差异均有统计学意义(P<0.01),ALB和β2-MG差异也有统计学意义(P<0.01),2型糖尿病患者的5项指标均高于健康对照组。结论血小板参数的不同变化和2型糖尿病患者微血管改变有关,ALB、β2-MG则是早期肾损害的最敏感的指标。 Objective To investigate the variation of PLT.microalbuminuria.13z MG and their clinical values of the patient with stype 2 diabete. Methods PLT,MPV.PDV and microalbuminuria.β2-MG were measured in 54 patients with type 2 diabetes and 39 healthy people. Results The differences between the 2 groups are great in every item except in PLT: PLT167±44.3(P〉0.05).MPVI3. 11±2.12(P〈0.01),PDW15.91±1.22(P〈0.01),urine Alb24.61 ±15.40(P〈0. 01),β2-MG0.61±0.30(P〈0. 01). These markers in group of type 2 diabetes were signifi- cantly higher than that of the normal controlone. Conclusion The variation of PLT markers is relevant to the changes of patients microvascular. Detection of microalbuminuria,β2-MG can provide the most impressive markers in the earlier period of kidney damage.
作者 周世亮
出处 《检验医学与临床》 CAS 2009年第13期1042-1042,1044,共2页 Laboratory Medicine and Clinic
关键词 2型糖尿病 血小板参数 尿微量清蛋白 Type 2 diabetes platelet parameters microalbuminuria
  • 相关文献

参考文献5

二级参考文献22

  • 1余裕民,顾康生.β_2-MG放射免疫测定及其临床应用(一)[J].蚌埠医学院学报,1990,15(4):223-226. 被引量:2
  • 2American Diabetes Association. Screening for type 2 diabetes[J]. Diabetes Care,2000,23(suppl 1):s20-s23.
  • 3Grundy S M, Benjamin I J, Burke G L, et a1. Diabetes and cardiovascular disease. A statement for health care professionals from the American Heart Association[J]. Circulation, 1999,100:1134-1136.
  • 4McGiIl H C, McMaban A, Malcolm G T, et al. Relation of glycohemoglobin and adiposity in youth [J].Arterioscler Thromb Vasc Biol, 1999,15:431-440.
  • 5Turner R C, Millns H, Neil H A W, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS:23)[J]. BMJ,1998,318:823-828.
  • 6Stratton I M, Adler A I, Neil H A. Association of glycaemia with macrovascular and microvascular complication of type 2 diabetes (UKPDS:35): prospective observational study[J]. BMJ, 2000, 321:405-412.
  • 7Anderson D K A,Svardsudd K.Long-term glycemic control relates to mortality in type II diabetes[J]. Diabetes Care, 1995,18:1534-1543.
  • 8Abu-lebden H S,Hodge D O,Nguyen T T,et al. Predictors of macrovascular disease in patients with type2 diabetes mellitus [J].Mayo Clin Proc,2001,76:707-712.
  • 9Tominaga M, Eguchi H,Manaka H,et al. Impaired glucose tolerance is a risk factor for cardiovascular disease,but not impaired fasting glucose[J]. Diabetes Care, 1999,22:920-924.
  • 10Asakawa H, Tokunaga K, Kawakami F. Comparison of risk factors of macrovascular complications. Peripheral vascular disease, cerebral vascular disease,and coronary heart disease in Japanses type 2 diabetes mellitus patients[J]. J Diabetes Comp,2000,14:307-313.

共引文献101

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部